24 Recruiting Cancer Phase 1 Clinical Trials
Active phase 1 studies for cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Cancer studiesPhase 1 Studies for Cancer
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
📍 Research Site — La Jolla, California
View Study & Checklist ➔ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
📍 Cedars Sinai-The Angeles Clinic — Los Angeles, California
View Study & Checklist ➔Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of TAVO412 in Patients with Cancer
📍 Tisch Cancer Center — New York, New York
View Study & Checklist ➔A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
📍 Highlands Oncology Group, PA /ID# 218863 — Springdale, Arkansas
View Study & Checklist ➔TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
📍 Arizona Oncology Associates — Tucson, Arizona
View Study & Checklist ➔FOG-001 in Locally Advanced or Metastatic Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Impact of Daily Oral Cannabis Doses in Patients With Cancer
📍 University of Kentucky — Lexington, Kentucky
View Study & Checklist ➔Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
📍 Horizon Oncology Research, LLC, — Lafayette, Indiana
View Study & Checklist ➔A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
📍 Research Site — Orlando, Florida
View Study & Checklist ➔A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
📍 Carolina BioOncology Institute — Huntersville, North Carolina
View Study & Checklist ➔A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
📍 Centre hospitalier de l'Université de Montréal (CHUM) — Montreal, Quebec
View Study & Checklist ➔Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
📍 BRCR Global — Plantation, Florida
View Study & Checklist ➔Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
📍 USC/Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
📍 Stanford University Cancer Institute — Stanford, California
View Study & Checklist ➔Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
📍 UCLA Health — Los Angeles, California
View Study & Checklist ➔Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
📍 NEXT Austin — Austin, Texas
View Study & Checklist ➔